Raloxifene Teva

/ Teva

The recommended dosage is one 60 mg tablet daily, which may be administered any time of day without regard to meals. For the indications in risk of invasive breast cancer the optimum duration of treatment is not known.
Recommendations for Calcium & Vitamin D Supplementation: For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate. Postmenopausal women require an average of 1500 mg/day of elemental calcium. The recommended intake of vitamin D is 400-800 IU daily.
Patients at increased risk for vitamin D insufficiency (e.g., over the age of 70 years, nursing home bound, or chronically ill) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplementation and measurement of 25-hydroxyvitamin D should be considered.

Treatment of osteoporosis in post menopausal women. Prevention of osteoporosis in post menopausal women.

Hypersensitivity to any ingredient of the product.
Women with active or past history of venous thromboembolism (VTE), including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis.
Pregnancy, women who may become pregnant, and nursing mothers.
Hepatic impairment including cholestasis.
Severe renal impairment.
Patients with signs or symptoms of endometrial cancer.
Unexplained uterine bleeding.
Patient who expect to be immobile for a long time.

See prescribing information for full details.

This drug is contraindicated in pregnancy, women who may become pregnant and nursing mothers.